SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kabra Drugs plans expansion Programme for export and quality product

05 Jan 2015 Evaluate

Kabra Drugs is planning Expansion and W.H.O. Specification Implementation, for export and quality product. The company is also planning expansion in Cosmetic Section, Deodorant and Perfumes etc. Construction of premises is in full having approximate time expected in implementing all these programme is about one year. The company is also starting Production of herbal products.

Kabra Drugs is the only manufacturer of Ether derivatives in the State of M.P. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. The company is also a registered supplier to the Ministry of Defence.

Kabra Drugs Share Price

26.05 -0.73 (-2.73%)
12-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.90
Dr. Reddys Lab 1270.10
Cipla 1292.00
Zydus Lifesciences 930.75
Lupin 2246.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×